跳至主要内容
临床试验/NCT05345184
NCT05345184
已完成
不适用

Feasibility, Acceptability, and Preliminary Effectiveness of a Cognitive Behavioral Suicide Prevention-focused Intervention Tailored to Adults Diagnosed With Schizophrenia Spectrum Disorders: Aim 2 RCT

University of Michigan1 个研究点 分布在 1 个国家目标入组 51 人2022年9月1日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Suicide
发起方
University of Michigan
入组人数
51
试验地点
1
主要终点
Calgary Depression Rating Scale (CDRS)
状态
已完成
最后更新
上个月

概览

简要总结

Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.

注册库
clinicaltrials.gov
开始日期
2022年9月1日
结束日期
2025年5月1日
最后更新
上个月
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Lindsay Bornheimer

Assistant Professor

University of Michigan

入排标准

入选标准

  • Schizophrenia Spectrum Disorder
  • Suicide ideation and/or attempt within 3 months of screening
  • Ability to speak and read in English
  • 18 to 65 years of age

排除标准

  • Requiring emergency care (e.g. imminent plan to harm self) as determined by trained research staff administering the Columbia-Suicide Severity Rating Scale (C-SSRS)
  • Inappropriate for behavioral treatment according to own judgment in consultation with a treating clinician CMH
  • Impaired capacity (cognitive capacity)

结局指标

主要结局

Calgary Depression Rating Scale (CDRS)

时间窗: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).

A scale to measure depression, higher scores indicate greater depression (range of 0-27)

Positive and Negative Syndrome Scale (PANSS)

时间窗: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).

A scale to measure psychosis symptoms, higher scores indicate greater psychosis (range of 30-210)

Columbia Suicide Severity Rating Scale (C-SSRS)

时间窗: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).

A scale to measure suicide thoughts and behavior, higher scores indicate greater suicide thoughts and behavior (range of 0-5)

次要结局

  • Beck Hopelessness Scale(4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).)
  • Defeat Scale (D Scale)(4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).)
  • The Entrapment Scale(4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).)

研究点 (1)

Loading locations...

相似试验